EMBL -EBI: Virtual Event, Tuesday 10th November 2020

Background & Motivation
• Digital Endpoints/Biomarkers based on mobile devices and sensor technology are currently
being investigated in many clinical studies
• Data collected from sensors is entirely different from any other clinical data collected
• No agreement or guidance on how to best process and analyse sensor data exists
• First guidance proposals on how to develop digital endpoints/biomarkers for clinical studies
only just appearing

• Overview on current strategies to develop digital endpoints/biomarkers
• Overview on current practices in collecting, processing and analyzing digital biomarker data
• Use cases from both academia and industry
• Analysis related issues like statistical methods for high-dimensional time series data;
addressing data types like touch and voice; relationship to disease and established clinical
• Data related issues like missing data, gathering, transferring, anonymizing, sharing

Anticipated workshop outcomes
• Shared understanding on current practices for digital biomarker data analysis in clinical
• Understanding current gaps and future steps of digital biomarker data analysis

Click here for information and registration

Content courtesy of EMBL -EBI

Related Post

  • Posted on 30 May, 2024
    Join Redenlab at the upcoming Huntington’s Disease Society of America (HDSA) National Convention, starting on the 30th of May 2024...
    • Posted on 4 March, 2023
      Join World BI for its 23rd rebranded edition of the Digital Health Innovation in Clinical Trials, Drug Development and Mobile...
      • Posted on 17 November, 2022
        The 4th Annual Kabuki Syndrome Foundation Research Conference to be held virtually on Friday, November 4, 2022. The Annual Conference...